Background & Aim:Throughout the past three decades, scientific attention has been increased in examining Unani drugs for a potential therapeutic or preventive agent in the management of a number of health disorders in general and skin disorder in particular. The pur
More
Background & Aim:Throughout the past three decades, scientific attention has been increased in examining Unani drugs for a potential therapeutic or preventive agent in the management of a number of health disorders in general and skin disorder in particular. The purpose of this systematic review is to analyze and categorize the current state of scientific evidence from clinical studies regarding the efficacy of Unani drugs in skin diseases. Experimental:Electronic and non-electronic systematic searches were carried out to identify all relevant clinical research on Unani drugs. Reference lists of articles that met the inclusion criteria were searched. Only studies reported in English were reviewed. Studies on single Unani drugs and compound formulations in various skin diseases were included, in accordance with the PRISMA statement that included studies must measure a physiological and/or a behavioral outcome. Results:The studies that met our inclusion criteria are effects of Unani drugs on Acne (n=5), Melasma (n=2), Pityriasis (n=1), Vitiligo (n=2), Urticaria (n=2), Ring worm (n=2), Psoriasis (n= 3), Eczema (n = 2), and Scabies (n = 1). The data from these studies support the efficacy of Unani drugs as compared to placebo and standard drugs in improving Acne, Melasma, Pityriasis, Vitiligo, Urticaria, Ring worm, Psoriasis, Eczema and Scabies. Recommended applications/industries:Findings from initial clinical trials suggest that Unani drugs may improve the clinical manifestations of skin diseases. However, larger multi-site clinical trials are needed to extend these preliminary findings.
Manuscript profile
